Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer
NCT01523457
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
75
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Pancreatic Cancer
Pancreatic Cancer
Interventions
DRUG:
Folfirinox
Sponsor
Yale University